Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder of unknown origin and
the most common interstitial lung disease. It progresses with the recruitment of fibroblasts …

Pulmonary fibrosis is a chronic and progressive lung disease characterized by the
accumulation of scar tissue in the lungs, which leads to impaired lung function and reduced …

Trabecular meshwork (TM) tissue is subjected to constant mechanical stress due to the
ocular pulse created by the cardiac cycle. This brings about alterations in the membrane …

Pulmonary fibrosis (PF) can be idiopathic or driven by a specific insult or disease process.
Inflammation plays a role in the pathophysiology, the extent of which remains a longstanding …

Ozone (O 3) is a major air pollutant that directly threatens the respiratory system, lung fatty
acid metabolism disorder is an important molecular event in pulmonary inflammatory …

Background Abnormal lipid metabolism has recently been reported as a crucial signature of
idiopathic pulmonary fibrosis (IPF). However, the origin and biological function of the lipid …

Two anti-fibrotic drugs, pirfenidone (PFD) and nintedanib (NTD), are currently used to treat
idiopathic pulmonary fibrosis (IPF). Peripheral blood mononuclear cells (PBMCs) are …

Fibrosis occurs in many organs, and its sustained progress can lead to organ destruction
and malfunction. Although numerous studies on organ fibrosis have been carried out, its …

Background and Objectives: Assessment of the prothrombotic, proinflammatory, and
functional status of a cohort of COVID-19 patients at least two years after the acute infection …

Pulmonary fibrosis (PF) is a serious lung disease characterized by diffuse alveolitis and
disruption of alveolar structure, with a poor prognosis and unclear etiopathogenesis. While …